Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00952055 · ClinicalTrials.gov registry record
Effects of Standard Treatment of Acute Coronary Syndromes on Macrophage Activity as Measured by Serum Neopterin
A clinical trial, sponsored by Winthrop University Hospital.
- Terminated
- Registry status
- 152
- Enrollment target
NCT00952055 is a clinical trial that was terminated before completion, run by Winthrop University Hospital. The registered enrollment target is 152 participants.
The verdict
NCT00952055 was terminated before completion, sponsored by Winthrop University Hospital.
- TERMINATED
- Registry status
- 152 participants
- Enrollment target
Study Summary
This is a prospective observational study focused on monitoring the effects of various treatment options for acute coronary syndrome (ACS) patients by measuring serum neopterin levels. Serum neopterin is a marker for measuring macrophage activation. Prior studies have illustrated that there are elevated serum neopterin levels in ACS. Patients enrolled are those with ACS. Blood samples are drawn at presentation, and at 72 hours after admission, or at office visits and at 72 hours later. Neopterin levels are measured via a commercially available assay..
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2003-07 |
| Est. Completion | 2011-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00952055
The ClinicalTrials.gov registry entry for NCT00952055 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Winthrop University Hospital, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00952055 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00952055 about?
NCT00952055 is a clinical study titled "Effects of Standard Treatment of Acute Coronary Syndromes on Macrophage Activity as Measured by Serum Neopterin". This is a prospective observational study focused on monitoring the effects of various treatment options for acute coronary syndrome (ACS) patients by measuring serum neopterin levels. Serum neopterin is a marker for measuring macrophage activation. Prior studies have illustrated that there are elev...
What is the current status of trial NCT00952055?
This trial is currently terminated. The enrollment target is 152 participants. The study started on 2003-07. Estimated completion is 2011-08.
Who is sponsoring clinical trial NCT00952055?
This trial is sponsored by Winthrop University Hospital, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.